Search - tctmd.com

Displaying 201 - 220 of 248

Sort: Relevancy | Date

News Daily News

Low BMI in and of Itself Portends Poor Survival After Acute MI

Caitlin E. Cox

April 21, 2016

News Daily News

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Michael O'Riordan

March 31, 2016

News Daily News

No Sign of Cardiovascular Risks With SSRI Antidepressants in Younger Patients

Yael L. Maxwell

March 24, 2016

News Daily News

Europeans Issue Guidance on Direct Discharge of Acute Heart Failure Patients From ED

Todd Neale

February 23, 2016

News Industry News

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

February 17, 2016

News Daily News

High Baseline Fitness Level Tied to Improved Survival After MI

Michael O'Riordan

February 01, 2016

News Daily News

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

Caitlin E. Cox

January 25, 2016

News Daily News

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Michael O'Riordan

January 12, 2016

News Daily News

Positive Attitude After ACS Translates Into Fewer Hospital Readmissions at 6 Months

Caitlin E. Cox

December 08, 2015

News Daily News

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Michael O'Riordan

December 02, 2015

News Industry News

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

November 23, 2015

News Industry News

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

November 04, 2015

News Daily News

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Yael L. Maxwell

November 04, 2015

News Daily News

Younger Women With STEMI More Likely Than Men to Die In-Hospital

L.A. McKeown

October 28, 2015

News Conference News TCT 2015

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Nicole Lou

October 13, 2015

News Industry News

Ventrix Initiates Clinical Trial of VentriGel™

September 17, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Industry News

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

September 08, 2015

News Industry News

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

September 03, 2015

News Conference News ESC 2015

BACC: Rapid Rule Out Protocol Safe for Acute MI Diagnosis

Yael L. Maxwell

August 30, 2015

Advertisement

Low BMI in and of Itself Portends Poor Survival After Acute MI

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

No Sign of Cardiovascular Risks With SSRI Antidepressants in Younger Patients

Europeans Issue Guidance on Direct Discharge of Acute Heart Failure Patients From ED

TherOx Enrolls First Patient in Study of Next-Generation Supersaturated Oxygen Therapy for AMI

High Baseline Fitness Level Tied to Improved Survival After MI

AHA Document Builds the Case for How to Improve Outcomes for Women With Acute MI

High Level of Gut Metabolite Predicts Worse Outcomes in ACS Patients

Positive Attitude After ACS Translates Into Fewer Hospital Readmissions at 6 Months

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Regeneron and Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent® Injection Fully Enrolled

TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI

Medicare Part D Has Scant Effect on Outcomes for Acute MI Patients

Younger Women With STEMI More Likely Than Men to Die In-Hospital

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Ventrix Initiates Clinical Trial of VentriGel™

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

New Haven Pharmaceuticals Receives FDA Approval for DURLAZA™ (aspirin) Extended Release Capsules for Secondary Prevention of Stroke and Acute Cardiac Events

US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack

BACC: Rapid Rule Out Protocol Safe for Acute MI Diagnosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content